Increased tumor stiffness has a strong impact on cancer progression by activating oncogenic intracellular signaling, such as Akt, β-catenin, focal adhesion kinase (FAK) and phosphatidylinositol 3-kinase (PI3K) pathways, while simultaneously inhibiting tumor suppressor genes for phosphatase and tensin homolog (PTEN) and glycogen synthase kinase 3α/β (GSK3α/β) [164]. Here, PTEN is linked to neoplasm.